SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-299563"
 

Sökning: id:"swepub:oai:DiVA.org:uu-299563" > Adapted Treatment G...

  • Johnson, PeterUniv Southampton, Canc Res UK Ctr, Southampton SO16 6YD, Hants, England. (författare)

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma

  • Artikel/kapitelEngelska2016

Förlag, utgivningsår, omfång ...

  • 2016
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-299563
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-299563URI
  • https://doi.org/10.1056/NEJMoa1510093DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • BACKGROUND We tested interim positron-emission tomography-computed tomography (PET-CT) as a measure of early response to chemotherapy in order to guide treatment for patients with advanced Hodgkin's lymphoma. METHODS Patients with newly diagnosed advanced classic Hodgkin's lymphoma underwent a baseline PET-CT scan, received two cycles of ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapy, and then underwent an interim PET-CT scan. Images were centrally reviewed with the use of a 5-point scale for PET findings. Patients with negative PET findings after two cycles were randomly assigned to continue ABVD (ABVD group) or omit bleomycin (AVD group) in cycles 3 through 6. Those with positive PET findings after two cycles received BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone). Radiotherapy was not recommended for patients with negative findings on interim scans. The primary outcome was the difference in the 3-year progression-free survival rate between randomized groups, a noninferiority comparison to exclude a difference of 5 or more percentage points. RESULTS A total of 1214 patients were registered; 937 of the 1119 patients (83.7%) who underwent an interim PET-CT scan according to protocol had negative findings. With a median follow-up of 41 months, the 3-year progression-free survival rate and overall survival rate in the ABVD group were 85.7% (95% confidence interval [CI], 82.1 to 88.6) and 97.2% (95% CI, 95.1 to 98.4), respectively; the corresponding rates in the AVD group were 84.4% (95% CI, 80.7 to 87.5) and 97.6% (95% CI, 95.6 to 98.7). The absolute difference in the 3-year progression-free survival rate (ABVD minus AVD) was 1.6 percentage points (95% CI, -3.2 to 5.3). Respiratory adverse events were more severe in the ABVD group than in the AVD group. BEACOPP was given to the 172 patients with positive findings on the interim scan, and 74.4% had negative findings on a third PET-CT scan; the 3-year progression-free survival rate was 67.5% and the overall survival rate 87.8%. A total of 62 patients died during the trial (24 from Hodgkin's lymphoma), for a 3-year progression-free survival rate of 82.6% and an overall survival rate of 95.8%. CONCLUSIONS Although the results fall just short of the specified noninferiority margin, the omission of bleomycin from the ABVD regimen after negative findings on interim PET resulted in a lower incidence of pulmonary toxic effects than with continued ABVD but not significantly lower efficacy.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Federico, MassimoUniv Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy. (författare)
  • Kirkwood, AmyCanc Res UK, London, England.;UCL, Canc Trials Ctr, London, England. (författare)
  • Fossa, AlexanderOslo Univ Hosp, Dept Med Oncol, Oslo, Norway. (författare)
  • Berkahn, LeanneAuckland City Hosp, Dept Haematol, Auckland, New Zealand. (författare)
  • Carella, AngeloSan Martino Univ Hosp, Dept Hematol, Genoa, Italy. (författare)
  • d'Amore, FrancescoAarhus Univ Hosp, Dept Hematol, DK-8000 Aarhus, Denmark. (författare)
  • Enblad, GunillaUppsala universitet,Experimentell och klinisk onkologi(Swepub:uu)gunienbl (författare)
  • Franceschetto, AntonellaUniv Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy. (författare)
  • Fulham, MichaelRoyal Prince Alfred Hosp, Dept Mol Imaging, Sydney, NSW, Australia. (författare)
  • Luminari, StefanoUniv Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy.;IRCCS, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy. (författare)
  • O'Doherty, MichaelKings Coll London, Kings Hlth Partners, St Thomas Hosp, PET Imaging Ctr, London WC2R 2LS, England. (författare)
  • Patrick, PipCanc Res UK, London, England.;UCL, Canc Trials Ctr, London, England. (författare)
  • Roberts, ThomasCanc Res UK, London, England.;UCL, Canc Trials Ctr, London, England. (författare)
  • Sidra, GamalLincoln Cty Hosp, Dept Haematol, Lincoln, England. (författare)
  • Stevens, LindseyCanc Res UK, London, England.;UCL, Canc Trials Ctr, London, England. (författare)
  • Smith, PaulCanc Res UK, London, England.;UCL, Canc Trials Ctr, London, England. (författare)
  • Trotman, JudithUniv Sydney, Concord Repatriat Gen Hosp, Sydney, NSW 2006, Australia. (författare)
  • Viney, ZaidKings Coll London, Kings Hlth Partners, St Thomas Hosp, PET Imaging Ctr, London WC2R 2LS, England. (författare)
  • Radford, JohnChristie Hosp, Dept Med Oncol, Manchester, Lancs, England. (författare)
  • Barrington, SallyKings Coll London, Kings Hlth Partners, St Thomas Hosp, PET Imaging Ctr, London WC2R 2LS, England. (författare)
  • Univ Southampton, Canc Res UK Ctr, Southampton SO16 6YD, Hants, England.Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy. (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:New England Journal of Medicine374:25, s. 2419-24290028-47931533-4406

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy